• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXT231416
Medical Device Problem Codes Patient-Device Incompatibility (2682); Migration (4003)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 07/28/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Age at the time of event/date of birth: asked but unavailable.Patient weight: asked but unavailable.Other relevant history, including preexisting medical conditions: asked but unavailable.Concomitant medical products and therapy dates: asked but unavailable.
 
Event or Problem Description
On (b)(6) 2009 the patient underwent endovascular treatment of an abdominal aortic aneurysm using gore® excluder® aaa endoprostheses.On an unknown date, proximal migration (distance unknown) of the ipsilateral leg of the trunk-ipsilateral leg component located on the patient's right side, and aneurysm enlargement (amount unknown) were observed.The physician stated that approximately 10 years after the initial procedure it was noted that the vessel diameter where the ipsilateral limb was located had enlarged, and the limb migrated.On (b)(6) 2020 the patient underwent reintervention.A gore® excluder® aaa contralateral leg component was used to extend the ipsilateral leg distally.The patient tolerated the procedure.
 
Additional Manufacturer Narrative
H.6.Conclusions code 2: code 22 - according to the gore® excluder® aaa endoprosthesis instructions for use (ifu), potential device or procedure-related adverse events that may occur and/or require intervention include, but are not limited to, component migration, dilatation, and aneurysm enlargement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10460907
Report Number2953161-2020-01012
Device Sequence Number19555548
Product Code MIH
UDI-Device Identifier00733132610150
UDI-Public00733132610150
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2009
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/29/2012
Device Model NumberPXT231416
Device Catalogue NumberPXT231416
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/28/2020
Supplement Date Received by Manufacturer09/17/2020
Initial Report FDA Received Date08/27/2020
Supplement Report FDA Received Date09/28/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-